Literature DB >> 26216030

Inflammasome activation in the liver: Focus on alcoholic and non-alcoholic steatohepatitis.

Gyongyi Szabo1, Arvin Iracheta-Vellve2.   

Abstract

Upregulation of the inflammatory cascade is a major element both in the progression of steatohepatitis to severe alcoholic hepatitis as well as in the progression of NASH to advanced NASH with fibrosis. The mechanisms underpinning these changes are only partially understood. Activation of the inflammatory cascade requires multiple stimuli and in this report, we discuss the role of inflammasomes that activate IL-1β as well as the sterile and pathogen-derived danger signals that results in inflammasome activation and inflammation in alcoholic and non-alcoholic steatohepatitis. The dynamics of inflammasome activation, the cell types involved and the trigger signals appear to be somewhat different between ASH and NASH. Further studies are needed to dissect the pathology-related differences between these two major forms of steatohepatitis. Clinical and therapeutic implications of inflammasome activation in steatohepatitis are also discussed.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26216030     DOI: 10.1016/j.clinre.2015.06.012

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  13 in total

Review 1.  The contrasting roles of inflammasomes in cancer.

Authors:  Qin He; Yu Fu; Dean Tian; Wei Yan
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  Interleukin-1 inhibition facilitates recovery from liver injury and promotes regeneration of hepatocytes in alcoholic hepatitis in mice.

Authors:  Arvin Iracheta-Vellve; Jan Petrasek; Benedek Gyogyosi; Shashi Bala; Timea Csak; Karen Kodys; Gyongyi Szabo
Journal:  Liver Int       Date:  2017-04-27       Impact factor: 5.828

3.  Time course of microglia activation and brain and blood cytokine/chemokine levels following chronic ethanol exposure and protracted withdrawal in rats.

Authors:  Manuel Sanchez-Alavez; William Nguyen; Simone Mori; Derek N Wills; Dennis Otero; Cindy L Ehlers; Bruno Conti
Journal:  Alcohol       Date:  2018-07-17       Impact factor: 2.405

Review 4.  Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.

Authors:  Thomas Greuter; Harmeet Malhi; Gregory J Gores; Vijay H Shah
Journal:  JCI Insight       Date:  2017-09-07

5.  The role of REV-ERB in NASH.

Authors:  Kristine Griffett; Matthew E Hayes; Michael P Boeckman; Thomas P Burris
Journal:  Acta Pharmacol Sin       Date:  2022-02-25       Impact factor: 7.169

Review 6.  GLP-1 mimetics as a potential therapy for nonalcoholic steatohepatitis.

Authors:  Yan Chen; Ying-Na Xu; Chen-Yu Ye; Wen-Bo Feng; Qing-Tong Zhou; De-Hua Yang; Ming-Wei Wang
Journal:  Acta Pharmacol Sin       Date:  2021-12-21       Impact factor: 7.169

7.  Time Course of Blood and Brain Cytokine/Chemokine Levels Following Adolescent Alcohol Exposure and Withdrawal in Rats.

Authors:  Manuel Sanchez-Alavez; William Nguyen; Simone Mori; Derek N Wills; Dennis Otero; Carlos A Aguirre; Mona Singh; Cindy L Ehlers; Bruno Conti
Journal:  Alcohol Clin Exp Res       Date:  2019-10-25       Impact factor: 3.455

8.  Role of FXR in Liver Inflammation during Nonalcoholic Steatohepatitis.

Authors:  Laura E Armstrong; Grace L Guo
Journal:  Curr Pharmacol Rep       Date:  2017-02-21

9.  Cathelicidin-related antimicrobial peptide alleviates alcoholic liver disease through inhibiting inflammasome activation.

Authors:  Fengyuan Li; Cuiqing Zhao; Tuo Shao; Yunhuan Liu; Zelin Gu; Mengwei Jiang; Huimin Li; Lihua Zhang; Patrick M Gillevet; Puneet Puri; Zhong-Bin Deng; Shao-Yu Chen; Shirish Barve; Leila Gobejishvili; Vatsalya Vatsalya; Craig J McClain; Wenke Feng
Journal:  J Pathol       Date:  2020-09-26       Impact factor: 7.996

10.  Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis.

Authors:  Daniel Cabrera; Alexander Wree; Davide Povero; Nancy Solís; Alejandra Hernandez; Margarita Pizarro; Han Moshage; Javiera Torres; Ariel E Feldstein; Claudio Cabello-Verrugio; Enrique Brandan; Francisco Barrera; Juan Pablo Arab; Marco Arrese
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.